A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's ...

As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

A Chinese biotech helmed by an AstraZeneca veteran has secured $108 million in series B funds, which the company will use to ...

French biotech company Abivax's shares rose by over 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly could ...

The latest announcement is out from Viva Biotech Holdings ( (HK:1873) ).

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

Congress is poised to pass the Biosecure Act after two years of incremental changes that watered down the bill’s curbs on Chinese biotechs ...